Patients with advanced CKD frequently develop disturbances in mineral and bone metabolism and fail to maintain normal systemic levels of calcium (Ca), inorganic phosphate (Pi), parathyroid hormone (PTH), and fibroblastic growth factor-23 (FGF23) (Moe et al. 2006). This evidence concerns the gene PTH and chronic kidney disease.